Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/20/2025 6:04:49 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 12531
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49872
Looks like no buying op today. Lets see if the
(4)
Squar
10/12/2018 2:50:47 PM
49871
I guess we agree that the negligible systemic
RusticBum
10/12/2018 2:35:22 PM
49870
I think in time we will find that proper yoga
(2)
Squar
10/12/2018 2:29:02 PM
49869
dunno .. imo NR signaled yesterday potential to
(1)
4kids
10/12/2018 2:25:35 PM
49868
the latter having been acquired by Pfizer in 2016
smokenhot
10/12/2018 2:09:41 PM
49867
Compare the "tingling" side effect of Brilacidin
(4)
Drano
10/12/2018 2:08:26 PM
49866
I absolutely agree with you. I just wanted to
(2)
RusticBum
10/12/2018 2:05:33 PM
49865
Could be...Leo could hand out $100 bills and
Commando911
10/12/2018 2:01:04 PM
49864
See 11 buys at .20 off the time and sales
(1)
NotRichYet2
10/12/2018 2:00:37 PM
49863
Ask is back at .20. They are probably trying to
(2)
Drano
10/12/2018 1:58:52 PM
49862
Maybe. Guessing they just couldn't find a 0.20
(2)
Squar
10/12/2018 1:35:53 PM
49861
yep and after hitting *high* of the day (HOD) ..
(3)
4kids
10/12/2018 1:34:32 PM
49860
Bid/ask was .18/.20 but that looked too positive
Drano
10/12/2018 1:30:34 PM
49859
yep PR email time stamp shows 1:17PM .. i have
(1)
4kids
10/12/2018 1:30:02 PM
49858
Oops, Im slow to trigger
Commando911
10/12/2018 1:24:01 PM
49857
Innovation Pharmaceuticals Brilacidin as a Novel
Commando911
10/12/2018 1:23:10 PM
49856
News just arrived via email. I agree nicely
AlanC
10/12/2018 1:22:28 PM
49855
Had a partial order fill just prior to the PR
(2)
4kids
10/12/2018 1:20:57 PM
49854
That isn't quite correct. PolyMedix had limited
(1)
Drano
10/12/2018 1:17:34 PM
49853
what i really like about today's update was its
(1)
4kids
10/12/2018 1:14:26 PM
49852
It's actually worse with Poly. They did lab tests
RusticBum
10/12/2018 1:13:58 PM
49851
Nice update! Keep working the plan Leo! Go
(2)
AlanC
10/12/2018 1:03:55 PM
49850
Yes, I was thinking about that also. There is
(1)
Jimmyboy
10/12/2018 12:49:52 PM
49849
You can tell that Leo DID NOT write that one --
(1)
Drano
10/12/2018 12:45:28 PM
49848
I'm convinced we are going to see some MAJOR
(1)
smokenhot
10/12/2018 12:28:16 PM
49847
Makes one wonder if it is the BP that is holding
(1)
petemantx
10/12/2018 12:27:38 PM
49846
It is amazing reading how varied are the pathways
(2)
petemantx
10/12/2018 12:23:29 PM
49845
Innovation Pharmaceuticals Brilacidin as a Novel
(3)
4kids
10/12/2018 12:20:13 PM
49844
Nice. They just keep connecting thise Celgene
Squar
10/12/2018 12:15:49 PM
49843
Innovation Pharmaceuticals Brilacidin as a Novel
(1)
BooDog
10/12/2018 12:15:12 PM
49842
IPIX News PDE4
(4)
smokenhot
10/12/2018 12:06:58 PM
49840
Well, with all the IPIX wealth we will soon have
Squar
10/12/2018 11:51:21 AM
49839
Ugh. Opdivo doesn't work for lung cancer.
Drano
10/12/2018 11:37:58 AM
49838
Absolutely. Just get ahold of a federal combined
(2)
BooDog
10/12/2018 10:06:59 AM
49837
"It's called distort and it has worked great
(4)
Kelt
10/12/2018 9:56:49 AM
49836
It's clear that people can't do their own
(5)
bejamin
10/12/2018 9:52:03 AM
49835
" All the recent volume is selling pressure.."
(5)
Kelt
10/12/2018 9:49:50 AM
49833
Many of the large non-profits like the cancer
(5)
Drano
10/12/2018 9:45:30 AM
49832
Every stock carries with it a RISK/REWARD factor.
(1)
NotRichYet2
10/12/2018 9:42:42 AM
49831
You attack the moderators and the bullish
(5)
Drano
10/12/2018 9:39:46 AM
49830
Yes, everyone that has been long this stock and
(1)
Jimmyboy
10/12/2018 9:24:41 AM
49829
I thought it was set up to be able to discuss
(5)
bejamin
10/12/2018 9:19:07 AM
49828
Let's see the partnership or BTD news in the next
BooDog
10/12/2018 9:17:56 AM
49827
JUST FOR THE RECORD --- DRANO is "NOT" the only
(2)
NotRichYet2
10/12/2018 9:17:12 AM
49826
That's what the ignore feature is for. Or at
(2)
BooDog
10/12/2018 9:05:29 AM
49825
This board was set up, I thought, to counter IHUB
(11)
petemantx
10/12/2018 9:02:37 AM
49824
Mo: Thanks for making it clear for all who own
(4)
AlanC
10/12/2018 8:59:03 AM
49823
I have a major beef with the Cancer Society but
(4)
petemantx
10/12/2018 8:57:33 AM
49822
Yes not following blindly and creating discussion
(4)
bejamin
10/12/2018 8:57:18 AM
49821
AGREE generally to all that is in your post. That
(4)
NotRichYet2
10/12/2018 8:33:57 AM
Newer
Older
Recent Articles
Understanding the TikTok Deal: Implications for ByteDance's Future
C3.ai Faces Class Action Lawsuit: Key Details for Investors
Class Action Notice for KinderCare Investors Amid Concerns
Investors Alert: Participate in Class Action Against SOC Now
Flywire Corporation Lawsuit Highlights Investor Rights Overview
ACI Learning Partners with OMREN for Enhanced Cybersecurity Skills
China World Summit Wing’s Vertical Run: A Community Celebration
Celebrating the Legacy of the Kashi Fair: A Cultural Journey
L Catterton's Investment Fuels Seki Furniture's Growth
Unveiling New Partnerships at the 2025 Media Cooperation Forum
Cathie Wood's Bold Investment Moves: Key Stock Adjustments
Snap Inc. Accused of Misleading Statements in Lawsuit
Wanda L. James Unveils Congressional Campaign for Change
Qlarant Joins Agile4Vets to Enhance Veteran Healthcare Services
Qlarant Joins Forces to Transform Veteran Healthcare Services
Sable Offshore faces investor lawsuit over production claims
Coty's Stock Troubles: A Deeper Look into Retail Challenges
AI Startup Born Secures $15 Million to Combat Loneliness
Elcogen Unveils Cutting-Edge Manufacturing Facility for Clean Energy
Trailblazer Merger Corporation I Reschedules Annual Meeting
Understanding the Fluor Corporation Class Action Lawsuit Details
Explore Artistic Possibilities with Wacom One 14 Pen Display
Ubiqconn and RuggON Present Innovative Solutions at TADTE
KT&G Showcases ESSE at Intertabac 2025 to Boost Global Reach
Investors Concerns Over Fly-E Group, Inc. Amid Class Action
Understanding Class Action Opportunities for Savara Investors
Diversified Energy's Secondary Offering: Key Insights Ahead
Cygnus Metals Boosts Resource Estimate in Copper-Gold Project
V.F. Corporation Class Action Lawsuit: Key Information for Investors
Diversified Energy's Recent Ordinary Shares Offering Explained
Transforming Client Care: Emily Mehr's Role at Sweet James
Beauty Power's Nail Care Set Wins Prestigious Beauty Award
Former CIA Officer Discusses AI Project Impact on America
Elliott Investment Management's Support for Workday's Future
The Journey of a $1000 Microsoft Investment Over 20 Years
Clorox Company Announces New Quarterly Dividend of $1.24
Savara Inc. Investors Get Opportunity for Class Action Suit
Investors Take Action in Lockheed Martin Securities Case
Investigation Launch by Rosen Law for Encompass Health Investors
Elliott Investment Management's Progressive Outlook on Workday
Landmark Study Highlights NobleStitch™ PFO Closure Benefits
Nxera Pharma Advances Immunotherapy Research in Cancer Clinical Trial
Western Forest Products Secures New US$30 Million Credit Facility
Western Forest Products Secures a New $30 Million Credit Facility
Discover the Growth Potential of Progressive Investments
Altimmune Investors Urged to Act Before Class Action Deadline
Revolutionizing Storytelling: Verily Storyworks Emerges
Breakthrough Results from ASC30 Study Unveiled at EASD Meeting
Navigating Opportunities in Recent Sable Offshore Corp. Lawsuit
Eisai's Etalanetug Tau Antibody Receives FDA Fast Track Status